Tari A. King
YOU?
Author Swipe
View article: Evaluating the Implementation and Maintenance of a Breast Cancer Risk-Assessment and Prevention Program
Evaluating the Implementation and Maintenance of a Breast Cancer Risk-Assessment and Prevention Program Open
Background Understanding factors associated with successful high-risk breast health programs can aid in the development of similar initiatives. This study evaluated the impact of the Breast Cancer Personalized Risk Assessment, Education, a…
View article: Preliminary Efficacy/Feasibility Study of a Breast Cancer-Related Lymphedema Prospective Screening and Early Intervention Program at the Dana-Farber Brigham Cancer Center
Preliminary Efficacy/Feasibility Study of a Breast Cancer-Related Lymphedema Prospective Screening and Early Intervention Program at the Dana-Farber Brigham Cancer Center Open
Background: Breast cancer-related lymphedema (BCRL) is a common and debilitating treatment-related adverse event that can profoundly impact quality of life and financial well-being. Although prospective surveillance and early intervention …
View article: Frailty and Postoperative Complications in Older Adults With Nonmetastatic Breast Cancer
Frailty and Postoperative Complications in Older Adults With Nonmetastatic Breast Cancer Open
This cross-sectional study investigates the association between frailty and postoperative complications in oncologic breast surgery among older adults with nonmetastatic breast cancer.
View article: Impact of age and treatment-related adverse events on financial toxicity among patients with breast cancer: a systematic review
Impact of age and treatment-related adverse events on financial toxicity among patients with breast cancer: a systematic review Open
Purpose Increasing incidence of breast cancer among young adults (YA), defined by the National Comprehensive Cancer Network (NCCN) as age < 40 years, has amplified concerns over financial toxicity (FT) in this demographic. This systematic …
View article: Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative breast cancer: a single-center prospective observational study
Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative breast cancer: a single-center prospective observational study Open
gov number, NCT03749421.
View article: Supplementary Figure S1 from Clinicogenomic Characterization of Inflammatory Breast Cancer
Supplementary Figure S1 from Clinicogenomic Characterization of Inflammatory Breast Cancer Open
Supplementary Figure S1. Landscape of TP53 alterations in IBC.
View article: Supplementary Figure S4 from Clinicogenomic Characterization of Inflammatory Breast Cancer
Supplementary Figure S4 from Clinicogenomic Characterization of Inflammatory Breast Cancer Open
Supplementary Figure S4. Days on CDK4/6i therapy by presence or absence of CCND1 amplification orTP53 alteration.
View article: Supplementary Figure S3 from Clinicogenomic Characterization of Inflammatory Breast Cancer
Supplementary Figure S3 from Clinicogenomic Characterization of Inflammatory Breast Cancer Open
Supplementary Figure S3. Expression of TP53 in IBC vs non-IBC.
View article: Data from Clinicogenomic Characterization of Inflammatory Breast Cancer
Data from Clinicogenomic Characterization of Inflammatory Breast Cancer Open
Purpose:Inflammatory breast cancer (IBC) is a rare and clinically distinct form of breast cancer associated with poor outcomes. The biological mechanisms driving IBC remain poorly understood, partly due to limited large-scale genomic studi…
View article: Supplementary Figure S2 from Clinicogenomic Characterization of Inflammatory Breast Cancer
Supplementary Figure S2 from Clinicogenomic Characterization of Inflammatory Breast Cancer Open
Supplementary Figure S2. Notch signaling pathway activation in IBC vs non-IBC; including HER2+ subset.
View article: Supplementary Tables S1-S15 from Clinicogenomic Characterization of Inflammatory Breast Cancer
Supplementary Tables S1-S15 from Clinicogenomic Characterization of Inflammatory Breast Cancer Open
Supplementary Tables S1-S15
View article: Racial‐ethnic variations in phyllodes tumors among a multicenter United States cohort
Racial‐ethnic variations in phyllodes tumors among a multicenter United States cohort Open
BACKGROUND AND OBJECTIVES: Previous studies have identified racial-ethnic differences in the diagnostic patterns and recurrence outcomes of women with phyllodes tumors (PT). However, these studies are generally limited in size and generali…
View article: Financial Difficulty Over Time in Young Adults With Breast Cancer
Financial Difficulty Over Time in Young Adults With Breast Cancer Open
IMPORTANCE Young adults aged 18 to 39 years represent the minority of breast cancer diagnoses but are particularly vulnerable to financial hardship. Factors contributing to sustained financial hardship are unknown. OBJECTIVES To identify f…
View article: Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study Open
PURPOSE The nodal burden of patients with residual isolated tumor cells (ITCs) in the sentinel lymph nodes (SLNs) after neoadjuvant chemotherapy (NAC) (ypN0i+) is unknown, and axillary management is not standardized. We investigated rates …
View article: Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆ Open
In this large cohort of patients with eTNBC treated with NAT, HER2-low status was not associated with pCR or survival after adjusting for clinical factors. The discordance in HER2 IHC pre- and post-NAT likely reflects challenges in HER2 qu…
View article: Regional Variation in Deescalated Therapy in Older Adults With Early-Stage Breast Cancer
Regional Variation in Deescalated Therapy in Older Adults With Early-Stage Breast Cancer Open
Importance Although trial data support the omission of axillary surgery and radiation therapy (RT) in women aged 70 years or older with T1N0 hormone receptor–positive (HR + ) breast cancer, potential overtreatment in older adults with frai…
View article: Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction
Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction Open
Importance Postmastectomy radiation therapy (PMRT) improves local-regional disease control and patient survival. Hypofractionation (HF) regimens have comparable efficacy and complication rates with improved quality of life compared with co…
View article: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study
The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study Open
Background Breast-conserving surgery (BCS) followed by adjuvant radiotherapy (RT) is a standard treatment for ductal carcinoma in situ (DCIS). A low-risk patient subset that does not benefit from RT has not yet been clearly identified. The…
View article: Factors Influencing Implementation of the Commission on Cancer’s Breast Synoptic Operative Report (Alliance A20_Pilot9)
Factors Influencing Implementation of the Commission on Cancer’s Breast Synoptic Operative Report (Alliance A20_Pilot9) Open
Background The technical aspects of cancer surgery have a significant impact on patient outcomes. To monitor surgical quality, in 2020, the Commission on Cancer (CoC) revised its accreditation standards for cancer surgery and introduced th…